lifestyle.californiaconsumerbanking.com

Author: Proscia

Proscia Wins 2026 MedTech Breakthrough Award for Turning the Moment of Diagnosis into Drug Development Insights

May 9, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete

May 7, 2026
Pathologie Friesland is Advancing Its Practice for Growth

May 6, 2026
Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings

April 29, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

April 24, 2026
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio

April 16, 2026
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

April 1, 2026
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

April 1, 2026
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors

March 18, 2026
NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscia’s Platform

March 10, 2026